Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 3 Initial Statement of Beneficial Ownership of HTML 6K
Securities by an Insider -- rrd38638.xml/2.1
2: EX-24 Power of Attorney HTML 5K
POWER OF ATTORNEY FOR SECTION 16 REPORTING
The undersigned hereby appoints Joseph K. Belanoff, in his capacity as
Chief Executive Officer of Corcept Therapeutics Incorporated (the "Company"),
Andrew Galligan, in his capacity as Chief Financial Officer of the Company, and
either of them with full power of substitution or their respective successors in any
such offices, as the attorney-in-fact of the undersigned to execute and file with the
Securities and Exchange Commission ("SEC") and any other authority required by
the rules and regulations of the SEC or any market or exchange on which shares of
the Company are traded and to submit to the Company, in the place and stead of
the undersigned, SEC Forms 3, 4 and 5 and any successor reporting forms
required by the SEC in connection with purchases and sales of securities of the
Company and any other transactions in securities of the Company reportable on
any such form. This Power of Attorney shall be effective until revoked by a
written instrument executed by the undersigned and delivered to the Company at
its headquarters to the attention of the Chief Financial Officer.
Dated: January 29, 2002
/s/ Alan F. Schatzberg
Name: Alan F. Schatzberg
Dates Referenced Herein and Documents Incorporated by Reference
